ADVANTAN Presentation Uses - Medsafe

ADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.

  Presentation, Advantan presentation uses, Advantan, Uses, Methylprednisolone aceponate, Methylprednisolone, Aceponate

LOXALATE 1. Product Name - Medsafe Home Page

Page 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.

  Risks, Combination

DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …

New Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …

  Sheet, Data, Data sheet, Clexane

SEPTANEST Articaine hydrochloride 4% with …

SEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.

  Articaine

BOOSTRIX - Medsafe Home Page

1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.

  Information, Boostrix

NEW ZEALAND DATA SHEET - Medsafe

NEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a

  Cymevene

Edition Draft - Medsafe

Part 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for

  Draft, Good, Practices, Manufacturing, Edition, Edition draft, Good manufacturing practice

Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …

New Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …

  Product, Name, Sheet, Data, Data sheet 1 product name

NEW ZEALAND DATA SHEET MESTINON® - Medsafe

NEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to

  Myasthenia, Gravis, Myasthenia gravis, Mestinon

DATA SHEET PREDNISONE - Medsafe

• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since

  Myasthenia, Gravis, Myasthenia gravis, Prednisone

i u ili - tevapharma.ch

ZNS Amisulprid Solian® Amisulprid-Mepha® ¢ Aripiprazol Abilify® Aripiprazol-Mepha®/ oro ¢ Buprenorphin Subutex® Buprenorphin-Mepha® ¢ Citalopram Seropram® Citalopram-Mepha® ¢

  Citalopram

ANXIETY DISORDER MEDICATION Generic/TRADE …

ANXIETY DISORDER MEDICATION Comparison Chart www.RxFiles.ca Brent Jensen BSP Sept 04

MEDICATIONS AND DYSPHAGIA SWALLOWING RISKS

DDS Health Standard 07-1 Guidelines for Identification and Management of Dysphagia and Swallowing Risks Attachment A 1 MEDICATIONS …

DRUG INDUCED QT PROLONGATION - GGC …

Issue 21, December 2012 Produced by NHS Greater Glasgow and Clyde Medicines Information Service . DRUG INDUCED QT PROLONGATION Prolongation of the QT interval can lead to a

  Drug, Induced, Drug induced qt prolongation, Prolongation

Chronic Illness Benefit medicine list (formulary) 2018

Chronic Illness Benefit medicine list (formulary) 2018 Who we are LA Health Medical Scheme (referred to as 'the Scheme’), registration number 1145, is a non-profit

  Benefits, Lists, Medicine, Chronic, Illness, Formulary, Chronic illness benefit medicine list

Table of Reported Drugs with Mitochondrial Toxicity

Table of Reported Drugs with Mitochondrial Toxicity Pharmacologic Category Toxin Action Symptoms 1. Anticonvulsants Valproate …

  Toxicity, Mitochondrial, Mitochondrial toxicity